BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
Seragon Pharmaceuticals is defunct.

Fate: Acquired by Genentech, Aug 2014 $725M + $1B Milestones; Acquired by JNJ Aug 2013 $650M + $350 Milestones


------------------
If you believe any of this information is incorrect, please let us know.